alcoholic fatty liver


Also found in: Dictionary, Thesaurus, Acronyms.
Related to alcoholic fatty liver: Alcoholic hepatitis

alcoholic fatty liver

A liver with acute and subacute (i.e., precirrhotic) changes induced by alcohol, a toxin that interferes with fatty acid oxidation, impairing the tricarboxylic acid cycle, resulting in incomplete beta-oxidation products from fatty acids.

alcoholic fatty liver

A liver with acute and subacute, ie precirrhotic, changes induced by alcohol, a toxin that interferes with fatty acid oxidation, impairing the tricarboxylic acid cycle, resulting in incomplete β-oxidation products from fatty acids. See Alcoholic cirrhosis. Cf Fatty liver of pregnancy.
Mentioned in ?
References in periodicals archive ?
According to the limited data available, the prevalence of non- alcoholic fatty liver ranges from 15 to 32 per cent in India.
Teetotallers also prone to fatty liver
Evaluation of risk factors of non alcoholic fatty liver disease (NAFLD) in a tertiary care hospital at Rawalpindi, Pakistan: a local experience.
COMPARISON OF SERUM LIPID PROFILE IN NON ALCOHOLIC FATTY LIVER DISEASE
* A review of the Non Alcoholic Fatty Liver Disease (NAFLD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
New Market Report: Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2014
Non alcoholic fatty liver diseaseand obesity: biochemical, metabolic and clinical presentations.
Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients
Frequency of non alcoholic fatty liver disease was 45.2% (222 out of 491 participants).
PREVALENCE OF NON ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME
* Identify and understand important and diverse types of therapeutics under development for Non Alcoholic Fatty Liver Disease (NAFLD).
New Report Available: Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2013
Since the unbalanced dietary consumption of n-6:n-3 PUFA is detrimental to human health, the impact of dietary supplementation with n-3 PUFA upon the alleviation of inflammatory diseases, more specifically, non alcoholic fatty liver disease, needs to be more thoroughly investigated.
Omega-6:omega-3 dietary ratio
Non alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations.
Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease
"Our study suggests that resveratrol may serve as a promising agent for preventing or treating human alcoholic fatty liver disease," the authors concluded.
Resveratrol may protect against alcoholic fatty liver disease
INTRODUCTION: Non alcoholic fatty liver disease (NAFLD) represents a spectrum of medical condition in which there is increased infiltration of fats, mostly triglycerides, cholesterol and phospholipids, in excess of 5-10% of liver weight 1 2.
Evaluation of cardiovascular risk by carotid intima media thickness in non alcoholic fatty liver disease
MATERIAL AND METHODS: The study was conducted on 50 diagnosed patients of non alcoholic fatty liver disease, with objective to identifying the association of various cardiovascular (ischemic heart disease) risk factor associated with it, like diabetes, hypertension, obesity, dyslipidemia etc.
Cardiovascular risk factors in patients with non alcoholic fatty liver disease
Alcoholic liver disease (ALD)-ranging from alcoholic fatty liver to alcohol induced liver fibrosis and cirrhosis-accounts for more than 50pc all chronic liver disease in industrialized countries.
Genetic variation linked to liver cirrhosis in alcoholic Caucasians identified

Medical browser ?
Full browser ?